Posted by Michael Wonder on 30 Apr 2026
Richter receives European Commission approval for Tuyory, its biosimilar tocilizumab in multiple indications
29 April 2026 - Gedeon Richter announces today that the European Commission granted marketing authorisation for Tuyory, its biosimilar to RoActemra tocilizumab.
The EC decision followed a positive opinion received from the CHMP of the EMA, as reported on 27 February 2026, and is applicable for the EU, Iceland, Liechtenstein and Norway.
